MRNS - Marinus Pharmaceuticals announces completion of enrollment in tuberous sclerosis complex program
2024-05-17 08:39:32 ET
More on Marinus Pharmaceuticals
- Marinus Pharmaceuticals, Inc. (MRNS) Q4 2023 Earnings Call Transcript
- Marinus stock falls 9% amid Q1 report, cost-cutting measures
- Marinus plummets 78% as phase 3 interim analysis of ganaxolone disappoints
- Seeking Alpha’s Quant Rating on Marinus Pharmaceuticals
- Historical earnings data for Marinus Pharmaceuticals